Pharmaceutical compositions with increased activity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S243000, C514S317000, C514S447000, C514S649000

Reexamination Certificate

active

08048882

ABSTRACT:
The invention relates to novel pharmaceutical combinations with improved sodium channel blocking effect. Further, the invention relates to the use of said pharmaceutical combinations in chronic pain, in disturbances of the motor system, in epilepsy, as well as in other therapeutic fields where the use of sodium channel blockers is acceptable.

REFERENCES:
patent: 4614499 (1986-09-01), Arseneault et al.
patent: 5735817 (1998-04-01), Shantha
patent: 6191142 (2001-02-01), Carson et al.
patent: 6673832 (2004-01-01), Davar
patent: 2001/0036943 (2001-11-01), Coe et al.
patent: 2002/0151543 (2002-10-01), Barberich et al.
Fitzgerald et al. Complications of antidepressants, anticonvulsants, and antiarrhythmics for chronic pain management. Techniques in Regional Anesthesia and Pain management, 1998. vol. 2, No. 3, pp. 119-129. ISSN:1084-208X.
Waldman et al. The pharmacologic management of neuropathic pain. Progress in Anesthesiology, 1998 vol. 12, No. 4, pp. 55-64. ISSN: 0891-5784.
Kaminska. New antiepileptic drugs in childhood epilepsies: Indcations and Limits. Epileptic Disorders, 2001 vol. 3, No. Spec. Issu. 2, pp. 37-46. ISSN: 1294-9361 (abstract).
Leander, Fluoxetine, a Selective Serotonin-Uptake Inhibitor, Enhances the Anticonvulsant Effects of Phenytoin, Carbamazepine . . . (LY201116), Epilepsia 33(3): 573-576 (1992).
Raju et al., Effect of Fluoxetine on Maximal Electroshock Seizures in Mice: Acute VS Chronic Administration, Pharm. Res. 39(6): 451-454 (1999).
Rapeport et al., Absence of a Sertraline-Mediated Effect on the Pharmacodynamics of Carbamazepine, J. Clin. Psych. 57: 20-23 (1996).
PCT International Search Report for PCT/HU2004/000123, (2004).
PCT Written Opinion for PCT/HU2004/000123, (2004).
PCT International Preliminary Report on Patentability (IPER) for PCT/HU2004/000123, (2004).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions with increased activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions with increased activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions with increased activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4311848

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.